logo

For the Inventor, By the Inventor

Romainville, France

Romain Luc Marie Gosmini

This inventor holds 11 USPTO granted patents and 4 EPO patents. Top assignees: Galapagos Nv, Abbvie S.a.r.l., Les Laboratoires Servier. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Romain Luc Marie Gosmini. Retrieved from https://idiyas.com/inventor/romain-luc-marie-gosmini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 81.8

 

Average Co-Inventor Count = 14.7

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Savigny-sur-Orge, FR (2017 - 2020)
  • Romainville, FR (2018 - 2023)

Company Filing History:

goldMedal11 out of 116 
 
Galapagos Nv
 patents
silverMedal5 out of 15 
 
Abbvie S.a.r.l.
 patents
bronzeMedal2 out of 296 
 
Les Laboratoires Servier
 patents
4. 1 out of 53 
 
Les Laboratories Servier
 patents
where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 11718588 - 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2023-08-08),
2. 10941117 - 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2021-03-09),
3. 10829478 - 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis (2020-11-10),
4. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2020-05-12),
5. 10550100 - 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis (2020-02-04),
6. 10487060 - 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2019-11-26),
7. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2019-04-16),
8. 10130622 - Compounds for treatment of cystic fibrosis (2018-11-20),
9. 9926281 - 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2018-03-27),
10. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2018-02-13),
11. 9796711 - [object Object] (2017-10-24),

Title: Romain Luc Marie Gosmini - Innovative Inventor from Romainville, FR

Introduction: Romain Luc Marie Gosmini is a renowned inventor hailing from Romainville, France, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Gosmini's latest patents include advancements in renewable energy technologies, sustainable materials, and cutting-edge medical devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Gosmini has established himself as a pioneer in the world of innovation, holding numerous patents that have significantly impacted industries worldwide. His dedication to pushing the boundaries of what is possible has earned him recognition as a visionary inventor.

Collaborations: Throughout his career, Gosmini has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His ability to work across disciplines and industries has led to the development of groundbreaking technologies that have the potential to shape the future.

Conclusion: Romain Luc Marie Gosmini's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of inventors and serves as a testament to the power of creativity and ingenuity in driving positive change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…